
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.04 | -9.67283072546 | 21.09 | 21.98 | 18.84 | 1557979 | 20.22746708 | CS |
4 | -2.29 | -10.7310215558 | 21.34 | 25.29 | 18.84 | 2110796 | 22.03316116 | CS |
12 | 0.425 | 2.28187919463 | 18.625 | 25.29 | 16.588 | 1556544 | 20.23710899 | CS |
26 | 8.05 | 73.1818181818 | 11 | 25.29 | 10.8127 | 1725933 | 17.72764654 | CS |
52 | 10.82 | 131.470230863 | 8.23 | 25.29 | 5.12 | 1427480 | 13.63948823 | CS |
156 | -6.91 | -26.6178736518 | 25.96 | 30.35 | 5.12 | 1268491 | 15.4265548 | CS |
260 | -6.1 | -24.254473161 | 25.15 | 33.0899 | 5.12 | 1103410 | 16.83445622 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales